Miras, Dionne Chixx .
HRN: 16-36-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/07/2022
12/14/2022
IV
240mg
Q8hours
Sepsis (Staphylococcus Epidermidis)
Waiting Final Action
Indication: Culture-directed Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes